» Articles » PMID: 30447075

Bioelectrical Impedance Analysis of Body Composition and Survival in Patients with Heart Failure

Overview
Journal Clin Cardiol
Date 2018 Nov 18
PMID 30447075
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies have shown that higher body mass index (BMI) is associated with improved prognosis in heart failure (HF), and this is often termed the obesity paradox.

Hypothesis: Analysis of body composition may reveal that muscle mass rather than adipose tissue accounts for the obesity paradox.

Methods: Bioelectrical impedance analysis of body composition in 359 outpatients with HF was performed using an In Body 520 body composition scale (Biospace Inc., California). Body fat and lean mass were indexed by height (m ). The cohort was stratified by median fat and lean mass indexed by height.

Results: The mean age of patients studied was 56 ± 14; mean left ventricular ejection fraction was 38 ± 16%. Patients with higher indexed body fat mass had improved 5-year survival over patients with lower indexed body fat mass (90.2% vs 80.1%, P = 0.008). There was also improved survival in patients with high vs low indexed lean body mass (89.3% vs 80.9%, P = 0.036). On multivariable analysis, higher indexed body fat mass, but not lean body mass, was independently associated with improved survival (HR 0.89, per kg/m increase in indexed body fat mass, P = 0.044); however, this was attenuated after adjustment for diabetes. The combination of low lean with low-fat mass was independently associated with poor prognosis.

Conclusions: Our data suggest that higher fat mass-and to a lesser extent higher lean mass-is associated with improved outcomes in HF. Further investigations of specific components of body composition and outcomes in HF are warranted.

Citing Articles

Association of Fontan Pathophysiology With Plasma Bile Acids.

Shah A, Surendran A, Hassan-Tash P, Turnbull C, Johnston N, Goodlett D JACC Adv. 2025; 4(2):101563.

PMID: 39827765 PMC: 11787425. DOI: 10.1016/j.jacadv.2024.101563.


Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease.

Lyu L, Wang X, Xu J, Liu Z, He Y, Zhu W Cardiovasc Diabetol. 2024; 23(1):162.

PMID: 38724999 PMC: 11080126. DOI: 10.1186/s12933-024-02213-2.


Sarcopenia is linked to higher levels of B-type natriuretic peptide and its N-terminal fragment in heart failure: a systematic review and meta-analysis.

Prokopidis K, Morwani-Mangnani J, McDowell G, Lip G, Venturelli M, Sankaranarayanan R Eur Geriatr Med. 2024; 15(4):893-901.

PMID: 38457043 PMC: 11377361. DOI: 10.1007/s41999-024-00950-x.


Fat Mass is Associated with Subclinical Left Ventricular Systolic Dysfunction in Patients with Type 2 Diabetes Mellitus Without Established Cardiovascular Diseases.

Liu J, Yang F, Sun Q, Gu T, Yao J, Zhang N Diabetes Ther. 2023; 14(6):1037-1055.

PMID: 37140878 PMC: 10203091. DOI: 10.1007/s13300-023-01411-7.


Reduced upper and lower limb muscle strengths without reduced skeletal muscle in elderly patients with heart failure.

Umehara T, Kaneguchi A, Yamasaki T, Katayama N, Kawakami W, Kuwahara D J Rural Med. 2023; 18(1):8-14.

PMID: 36700128 PMC: 9832311. DOI: 10.2185/jrm.2022-029.


References
1.
Streng K, Voors A, Hillege H, Anker S, Cleland J, Dickstein K . Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018; 20(9):1269-1277. DOI: 10.1002/ejhf.1244. View

2.
Zavin A, Daniels K, Arena R, Allsup K, Lazzari A, Joseph J . Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction. Int J Cardiol. 2012; 167(6):2468-71. PMC: 7240176. DOI: 10.1016/j.ijcard.2012.06.007. View

3.
Baumgartner R, Roche A, Guo S, Lohman T, Boileau R, Slaughter M . Adipose tissue distribution: the stability of principal components by sex, ethnicity and maturation stage. Hum Biol. 1986; 58(5):719-35. View

4.
Wilhelmsen L, Rosengren A, Eriksson H, Lappas G . Heart failure in the general population of men--morbidity, risk factors and prognosis. J Intern Med. 2001; 249(3):253-61. DOI: 10.1046/j.1365-2796.2001.00801.x. View

5.
Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N . Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail. 2018; 20(11):1580-1587. DOI: 10.1002/ejhf.1304. View